In a small case series, Burnett and colleagues [18] showed that daily PDE5 inhibitor therapy reduced ischemic priapism episodes in men with stuttering priapism, either idiopathic or due to sickle-cell disease, without modifying erectile function. The gene discussed is PDE5A; the disease is Priapism.